Study investigating the impact, risk and mechanisms of neuropathic pain (nerve pain) associated with chemotherapy. Partnership for Assessment and Investigation of Neuropathic Pain (PAINSTORM)
Chemotherapy is a vital cancer treatment, but certain drugs can damage nerves. This causes a condition called chemotherapy-induced peripheral neuropathy, leading to pain, tingling, or numbness in the hands and feet. Sometimes this pain is so bad that life-saving cancer treatment must be paused or reduced. The PAINSTORM study aims to understand why some people get nerve damage from chemotherapy while others do not. Researchers will follow adults starting cancer treatment over several months, using simple sensory checks, questionnaires, and health reviews. Taking part will not change your cancer medication, but it will help scientists learn what puts people at risk. The ultimate goal is to discover better ways to predict, stop, and treat nerve pain for people having cancer treatment in the future. The study is run from the University of Dundee and involves patients across the UK.
At a glance
What is this study about?
Chemotherapy is one of the most powerful tools we have to treat cancer. However, some types of chemotherapy can harm nerves outside the brain and spinal cord. Doctors call this chemotherapy-induced peripheral neuropathy. It often feels like tingling, burning, numbness, or shooting pains, usually starting in your toes or fingers. In some cases, the pain becomes so difficult that doctors have to lower your chemotherapy dose or stop it early.
Right now, doctors cannot predict who will develop this nerve pain and who will stay pain-free. We also do not have good treatments to stop it before it starts. Researchers know that a person's genetics, daily lifestyle, and past health might play a role, but they need clearer answers. This is where the PAINSTORM study comes in.
By taking part, you help scientists observe how nerves react throughout chemotherapy. Researchers will track changes in your nerve sensitivity and general well-being from before your treatment begins until after it finishes. While this research may not change your own treatment plan, it could protect future cancer patients from lasting nerve damage.
Key takeaways
- The PAINSTORM study looks at why chemotherapy causes nerve pain in some people but not others.
- It is for adults aged 18 to 75 who are about to start specific types of chemotherapy.
- You will attend three clinic visits for simple nerve checks and answer regular health surveys.
- The study does not change your cancer medication or treatment schedule.
- Taking part is voluntary, and you can leave at any time without affecting your NHS care.
Who may be eligible?
This study is open to adults aged 18 to 75 who are about to start a course of cancer chemotherapy known to carry a risk of nerve damage. This includes common treatments such as platinum drugs, taxanes, and certain targeted therapies. Both men and women can join.
You might not be able to join if you already suffer from moderate or severe long-term pain from another health issue, as this would make it tricky to tell what is causing your symptoms. You also cannot take part if you are very unwell, spend most of your day in bed due to poor health, or have serious conditions that prevent you from completing simple questionnaires or giving informed consent.
Your cancer care team and the research doctors will review your health records to make sure taking part is safe and practical for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am between 18 and 75 years old.
- I have been diagnosed with cancer and have not yet started my planned chemotherapy.
- My cancer doctor has told me my treatment could cause nerve side effects.
- I do not already have severe, unexplained pain from another illness.
- I am well enough to answer questions about my health and attend research visits.
What does participation involve?
If you take part, you will have three main hospital visits: one before your chemotherapy begins, one midway through, and one at the end of treatment. During these visits, the research team will check your height, weight, and general health. They will carry out simple, gentle nerve tests called sensory testing. This involves seeing how your skin feels light touches, warmth, coolness, or gentle pinpricks. You will also fill out surveys about your health and how you feel.
Between visits, you will complete short surveys from home before each chemotherapy cycle. Some optional parts of the study include giving a small blood sample, wearing a light activity tracker on your body for seven days, or having a brain MRI scan to check nerve pathways. After finishing chemotherapy, the team will check in with you by phone, post, or online at 3, 6, 9, and 12 months. Your total time in the study will be around one to two years.
Potential risks and benefits
Locations (2)
- Ninewells Hospital and Medical SchoolCity onlyDundee, Scotland
- University Hospitals Bristol NHS Foundation TrustCity onlyBristol, England
Common questions
Will taking part change my chemotherapy plan?
No. The study is purely observational. You will receive the exact cancer treatment your oncology team planned for you.
Are the nerve tests painful?
The tests check how your skin senses warmth, cold, and light touch. A gentle pinprick test is also used. These tests may feel briefly strange or slightly prickly, but they do not cause lasting pain.
Do I have to do the brain MRI scan?
No. The brain scan, blood tests, and activity tracker are completely optional. You can say no to them and still take part in the main study.
Can I leave the study if I feel too tired?
Yes. Chemotherapy can be exhausting. You are free to step down from the study at any point, and your normal cancer care will continue as usual.
Does taking part cost anything?
No, taking part is free. The study team can explain if any travel costs for research visits can be refunded.
How to find out more
Lesley Colvin
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.